You are here: Industry Insights > Brexit

News List

Brexit's trick or treat on patient safety cphi-online
May 05, 2019
Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation.
Pharma firms step up plans to beat Brexit supply chain disruption europeanpharmaceuticalreview
April 19, 2019
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39…
Brexit will have ‘minimal’ effect on R&D, expert says europeanpharmaceuticalreview
April 12, 2019
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK…
Brexit will have ‘minimal’ impact on R&D, expert says europeanpharmaceuticalreview
April 08, 2019
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK…
No-deal Brexit could mean temporary medicines export ban pharmatimes
April 02, 2019
The Association of the British Pharmaceutical Industry (ABPI) has called for a temporary ban on drugs exports in the event of a no-deal Brexit to prevent the NHS being hit by shortages.
UK Biotech still going strong at the start of 2019 pharmatimes
March 28, 2019
The UK BioIndustry Association (BIA) and Informa Pharma Intelligence have published figures revealing a strong start to 2019 for venture capital investment in UK biotech, despite the uncertainties of Brexit.
RAPS on delayed Brexit en-cphi.cn
March 28, 2019
The post-Brexit regulatory environment continues to weigh heavily on the minds of regulatory professionals.
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event pharmatimes
March 27, 2019
In the wake of Brexit and the event of a no-deal exit from the European Union, French pharmaceutical giant Sanofi has said it could potentially airlift its flu vaccine into the UK.
No-deal Brexit ‘catastrophic’ for science and innovation in the UK europeanpharmaceuticalreview
March 19, 2019
Seventy-two percent of chemistry professionals said that a no-deal Brexit would be “very negative” for the sector, survey finds…
Chemistry professionals say no-deal Brexit negative for UK science pharmatimes
March 14, 2019
An international survey commissioned by the Royal Society of Chemistry has revealed the scale of Brexit concern in the sector across the UK, EU and beyond.

Previous page 1 2 3 4 5 6 7 8 Next page